Adaptive Biotechnologies CorporationADPTNASDAQ
Loading
Cost of Revenue Over TimeStrong
Percentile Rank75
3Y CAGR+7.2%
5Y CAGR+25.9%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+7.2%/yr
vs +31.0%/yr prior
5Y CAGR
+25.9%/yr
Recent deceleration
Acceleration
-23.8pp
Decelerating
Percentile
P75
Within normal range
vs 5Y Ago
3.2x
Strong expansion
Streak
2 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $71.36M | -1.0% |
| 2024 | $72.08M | -4.6% |
| 2023 | $75.55M | +30.5% |
| 2022 | $57.91M | +17.5% |
| 2021 | $49.30M | +118.8% |
| 2020 | $22.53M | +1.1% |
| 2019 | $22.27M | +13.2% |
| 2018 | $19.67M | +25.4% |
| 2017 | $15.68M | - |